Mark J. Bishton, Rodney J. Hicks, David A. Westerman, Miles H. Prince, Max Wolf, John F. Seymour. A prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin’s lymphoma following treatment with iodine-131-rituximab radio-immunotherapy. haematol [Internet]. 2008Apr.30 [cited 2024Nov.25];93(5):789-90. Available from: https://haematologica.org/article/view/4858